Chemomab Therapeutics Ltd. (CMMB) DCF Valuation

Chemomab Therapeutics Ltd. (CMMB) DCF Valuation

IL | Healthcare | Biotechnology | NASDAQ
Chemomab Therapeutics Ltd. (CMMB) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Chemomab Therapeutics Ltd. (CMMB) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Gain insight into your Chemomab Therapeutics Ltd. (CMMB) valuation analysis using our state-of-the-art DCF Calculator! This Excel template comes preloaded with real (CMMB) data, enabling you to adjust forecasts and assumptions for a precise calculation of Chemomab Therapeutics Ltd.'s intrinsic value.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -26.9 -5.9 -12.3 -28.5 -25.4 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .3 .1 .0 .1 .1 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -27.2 -6.0 -12.4 -28.5 -25.5 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 17.6 11.7 61.2 39.9 19.8 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .6 .1 .2 .0 .3
Account Receivables, % 100 100 100 100 100
Inventories .0 -.7 -47.5 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .0 .1 1.3 1.7 .5 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.1 .0 -.2 -.1 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -27.2 -6.0 -12.4 -28.0 -25.5 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -27.6 -4.7 35.3 -75.0 -26.9 -.2 .0 .0 .0 .0
WACC, % 5.86 5.86 5.86 5.86 5.86 5.86 5.86 5.86 5.86 5.86
PV UFCF
SUM PV UFCF -.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -9
Equity Value 9
Diluted Shares Outstanding, MM 12
Equity Value Per Share 0.74

What You Will Receive

  • Customizable Excel Template: A fully adaptable Excel-based DCF Calculator featuring pre-filled real CMMB financials.
  • Real-World Data: Historical data and future estimates (highlighted in the yellow cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Instant Calculations: See the immediate effect of your inputs on Chemomab’s valuation.
  • Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Interface: Organized for clarity and convenience, complete with step-by-step guidance.

Key Features

  • 🔍 Real-Life CMMB Financials: Pre-filled historical and projected data for Chemomab Therapeutics Ltd.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Chemomab’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Chemomab’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Chemomab Therapeutics Ltd. (CMMB) data.
  • Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the updated results, including Chemomab Therapeutics Ltd.'s (CMMB) intrinsic value.
  • Step 5: Make well-informed investment decisions or create reports based on the outputs.

Why Choose This Calculator for Chemomab Therapeutics Ltd. (CMMB)?

  • Designed for Industry Experts: A specialized tool crafted for biopharma analysts, financial officers, and consultants.
  • Accurate Data: Chemomab’s historical and projected financials are preloaded for precision.
  • Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
  • Comprehensive Outputs: Automatically computes intrinsic value, NPV, and critical financial metrics.
  • User-Friendly: Clear, step-by-step instructions make the process straightforward.

Who Should Use This Product?

  • Investors: Assess Chemomab Therapeutics Ltd.'s (CMMB) potential for investment opportunities.
  • CFOs and Financial Analysts: Optimize valuation methodologies and evaluate financial forecasts for CMMB.
  • Startup Founders: Understand the valuation strategies of biotechnology firms like Chemomab Therapeutics Ltd. (CMMB).
  • Consultants: Create comprehensive valuation reports tailored for clients in the biotech sector.
  • Students and Educators: Utilize real-time data from Chemomab Therapeutics Ltd. (CMMB) to teach and practice valuation concepts.

What the Template Contains

  • Pre-Filled DCF Model: Chemomab Therapeutics Ltd.’s (CMMB) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Chemomab Therapeutics Ltd.’s (CMMB) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.